Bioactive β‐bend structures for the antagonist hα CGRP8–37 at the CGRP1 receptor of the rat pulmonary artery
Authors:
- 1 March 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (5) , 1049-1055
Abstract
The aim of this study was to determine beta-bend structures and the role of the N- and C-terminus in the antagonist halpha CGRP(8 - 37) at the rat pulmonary artery CGRP receptor mediating halpha CGRP relaxation. Halpha CGRP(8 - 37) Pro(16) (10(-6) M), with a bend-biasing residue (proline) at position 16, did not antagonize halpha CGRP responses, while a structure-conserving amino acid (alanine(16)) at the same position retained antagonist activity (apparent pK(B) 6.6+/-0.1; 10(-6) M). Halpha CGRP(8 - 37) Pro(19) (10(-6) M), with proline at position 19 was an antagonist (apparent pK(B) 6.9+/-0.1). Incorporation of a beta-bend forcing residue, BTD (beta-turn dipeptide), at positions 19 and 20 in halpha CGRP(8 - 37) (10(-6) M) antagonized halpha CGRP responses (apparent pK(B) 7.2+/-0.2); and BTD at positions 19,20 and 33,34 within halpha CGRP(8 - 37) was a competitive antagonist (pA(2) 7.2; Schild plot slope 1.0+/-0.1). Halpha CGRP(8 - 37) analogues, substituted at the N-terminus by either glycine(8) or des-NH(2) valine(8) or proline(8) were all antagonists (apparent pK(B) 6.9+/-0.1; (10(-6) M), 7.0+/-0.1 (10(-6) M), and pA(2) 7.0 (slope 1.0+/-0.2), respectively); while replacements by proline(8) together with glutamic acid(10,14) in halpha CGRP(8 - 37) (10(-6) M) or alanine amide(37) at the C-terminus of halpha CGRP(8 - 37) (10(-5) M) were both inactive compounds. In conclusion, possible bioactive structures of halpha CGRP(8 - 37) include two beta-bends (at 18 - 21 and 32 - 35), which were mimicked by BTD incorporation. Within halpha CGRP(8 - 37), the N-terminus is not essential for antagonism while the C-terminus may interact directly with CGRP(1) receptors in the rat pulmonary artery.Keywords
This publication has 30 references indexed in Scilit:
- Conformational restraints revealing bioactive β-bend structures for hα CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferensBritish Journal of Pharmacology, 1999
- Structural comparison of alanine‐substituted analogues of the calcitonin gene‐related peptide 8‐37 Importance of theC‐terminal segment for antagonistic activityInternational Journal of Peptide and Protein Research, 1996
- Constrained Analogues of the Calcitonin Gene-Related PeptideBiochemical and Biophysical Research Communications, 1994
- Structure-Activity Study of Chicken Calcitonin Gene-Related Peptide (CGRP) on Vasorelaxation in Rat Mesenteric Resistance Vessels.The Japanese Journal of Pharmacology, 1994
- Mechanism of Vascular Relaxation by the Calcitonin Gene‐Related PeptideaAnnals of the New York Academy of Sciences, 1992
- Characterization of CGRP1 and CGRP2 Receptor SubtypesaAnnals of the New York Academy of Sciences, 1992
- Calcitonin Gene-Related Peptide in the Regulation of Cardiac FunctionAnnals of the New York Academy of Sciences, 1992
- Antagonistic effect of human α-CGRP [8–37] on the in vivo regional haemodynamic actions of human α-CGRPBiochemical and Biophysical Research Communications, 1990
- Inhibition of periarterial nerve stimulation-induced vasodilation of the mesenteric arterial bed by CGRP (8–37) and CGRP receptor desensitizationBiochemical and Biophysical Research Communications, 1990
- Biological properties of two models of calcitonin gene related peptide with idealized amphiphilic .alpha.-helices of different lengthsBiochemistry, 1988